# Bunion Treatment Market

> Bunion (Hallux Valgus) Treatment Market Research Report Information By Diagnosis (Medical History, X-Rays, Radiography), By Treatment (Self-Care, Medications, Devices, Surgery), By End User (Healthcare Service Providers and Podiatrists), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.8%
- **2024:** $ 23.5 Million
- **2025:** $ 25.09 Million
- **2035:** $ 48.46 Million
- **Key Players:** Companies such as B. Braun Melsungen AG (DE), Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), DePuy Synthes (US), Smith & Nephew plc (GB), Acelity L.P. Inc. (US), Medtronic plc (IE), Orthofix Medical Inc.(US), Hanger, Inc. (US) are some of the major participants in the global market.

**Report ID:** MRFR/Pharma/3757-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** August 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/bunion-treatment-market-5195

---

## Market Summary

Global Bunion Treatment Market Size was valued at USD 23.50 Million in 2024 & the market is projected to grow from USD 25.09 Million in 2025 to USD 48.46 Million by 2035, registering a CAGR of 6.80% during the forecast period 2025–2035. North America led the market with over 44.68% share, generating around USD 10.5 Million in revenue.
 
The rising prevalence of hallux valgus, particularly among older adults, is increasing demand for surgical and conservative treatments. Greater diagnosis, aging populations, and improved access to orthopedic care are expanding the addressable patient pool and supporting continued growth in bunion treatment services.
 
A PubMed meta-analysis covering 45 studies and 186.3 million people estimated global hallux valgus prevalence at 19%, rising to 22.7% among adults over 60, highlighting substantial treatment potential.

## Market Drivers

### Rising Awareness and Education

Increased awareness about bunions and their treatment options is a crucial driver for the Global Bunion (Hallux Valgus) Treatment Market Industry. Educational campaigns by healthcare providers and associations have led to greater public knowledge regarding the condition and its implications.
 
Patients are now more informed about the available treatments, including both conservative and surgical options. This heightened awareness is likely to result in more individuals seeking medical advice and treatment, thereby expanding the market. As awareness continues to grow, it is anticipated that the demand for bunion treatments will further increase, contributing to market expansion.

- A PubMed systematic review and meta-analysis covering 45 studies and 186.3 million individuals estimated global hallux valgus prevalence at 19%, providing strong evidence of the condition’s substantial patient base and the importance of awareness, diagnosis, and access to treatment.

### Advancements in Surgical Techniques

Innovations in surgical procedures for bunion correction are significantly influencing the Global Bunion (Hallux Valgus) Treatment Market Industry. Minimally invasive techniques, such as the use of arthroscopy, have improved patient outcomes and reduced recovery times.
 
 These advancements not only enhance the effectiveness of treatments but also appeal to patients seeking quicker recovery. As a result, the market is projected to grow from 0.02 USD Billion in 2024 to 0.05 USD Billion by 2035, reflecting a compound annual growth rate (CAGR) of 9.34% from 2025 to 2035. This trend indicates a shift towards more efficient and patient-friendly treatment options.

- PubMed evidence demonstrates continued clinical value from modern surgical management. In a randomized trial of 209 patients, 83% of patients receiving surgery reported improvement at one year, compared with 46% receiving orthosis and 24% in the control group.

### Growing Adoption of Orthotic Devices

The Global Bunion (Hallux Valgus) Treatment Market Industry is also being propelled by the increasing adoption of [orthotic devices](https://www.marketresearchfuture.com/reports/orthotic-devices-market-2858). These devices, which include custom insoles and bunion splints, provide non-invasive treatment options that alleviate pain and improve foot function.
 
The growing trend towards preventive care and self-management of foot health has led to a rise in the use of these products. As consumers become more health-conscious, the demand for orthotic solutions is expected to grow. This trend is likely to contribute to the overall market growth, as more individuals seek effective, non-surgical alternatives for bunion treatment.

- A two-year PubMed follow-up study of 53 hallux valgus patients found that pain reductions from foot-orthosis treatment were maintained through 24 months, while 81% of participants continued using orthoses at the end of follow-up.

### Increasing Prevalence of Bunion Cases

The Global Bunion (Hallux Valgus) Treatment Market Industry is experiencing growth due to the rising prevalence of bunions among various demographics. Factors such as aging populations and lifestyle choices contribute to this increase.
 
For instance, bunions are more common in older adults, with studies indicating that approximately 23% of individuals aged 18-65 and 36% of those over 65 are affected. This growing incidence necessitates effective treatment options, thereby expanding the market. As the population continues to age, the demand for bunion treatments is expected to rise, further driving the market's growth.

- A large PubMed meta-analysis found hallux valgus prevalence of 23% among adults aged 18–65 and 35.7% among people over 65, demonstrating a substantially higher burden among older populations and supporting expanding demand for age-related foot-care and treatment solutions.

## Future Outlook

The Bunion Treatment Market size is projected to reach USD 48.46 Million by 2035, growing at a CAGR of 6.8%

**New opportunities:**

- Development of minimally invasive surgical techniques for bunion correction. Expansion of telehealth services for pre- and post-operative care. Introduction of customized orthotic solutions leveraging 3D printing technology.

By 2035, the Bunion Treatment Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Treatment Type: Surgical Treatment (Largest) vs. Non-Surgical Treatment (Fastest-Growing)

In the Bunion Treatment Market, Surgical Treatment currently holds the largest share of 55%, reflecting its longstanding recognition as an effective solution for severe bunion cases. Non-Surgical Treatment is gaining traction, driven by increasing patient awareness and preference for less invasive options. Orthotic Devices and Physical Therapy also contribute to the overall market dynamics but represent smaller portions of the market. This trend illustrates a balanced competition among various treatment options catering to diverse patient needs. Growth trends in the bunion treatment segment are heavily influenced by advancements in surgical techniques and increasing efficacy in non-surgical interventions. A rise in the aging population, which is more prone to bunions, supports the demand for effective treatment options. Additionally, developments in orthotic technology and increased access to [physical therapy services](https://www.marketresearchfuture.com/reports/physical-therapy-services-market-67558) help foster growth in these segments. The market is seeing a shift towards personalized treatment plans, further fueling these trends.

B. Braun Melsungen AG emphasizes agile, user-centered medical-technology R&D and specifically highlights expertise in minimally invasive surgery, supporting continued innovation around surgical treatment solutions.

### By Severity Level: Moderate (Largest) vs. Severe (Fastest-Growing)

In the Bunion Treatment Market, the distribution of market share among the severity levels reveals that the moderate segment occupies the largest share of 48%, capturing attention with its significant patient population seeking treatment. This is followed closely by the severe segment, which, while smaller in portion currently, is gaining ground due to increasing awareness and advancements in treatment options for more critical cases. The mild segment, although present, holds a lesser share compared to its more severe counterparts, indicating a shift toward addressing more pronounced conditions. As the market evolves, the growth trends show that the severe segment is the fastest-growing, primarily driven by an aging population, lifestyle changes, and heightened awareness regarding bunion treatment. With advancements in surgical techniques and a greater emphasis on addressing pain and mobility issues associated with severe bunions, healthcare providers are increasingly focusing on this segment. Consequently, this growth in severe cases is reflecting a broader trend within the healthcare sector, emphasizing the importance of addressing more complex conditions as patient needs evolve.

Stryker Corporation’s foot-and-ankle portfolio expansion through Artelon adds advanced soft-tissue fixation technology; Artelon had achieved over 60,000 implantations worldwide, strengthening treatment capabilities across orthopedic procedures.

### By Patient Demographics: Adults (Largest) vs. Seniors (Fastest-Growing)

In the Bunion Treatment Market, the patient demographics reveal that adults form the largest segment, encompassing a significant 64% share due to their prevalent lifestyle factors and foot conditions that lead to bunions. The younger adult population tends to seek proactive treatment solutions, contributing to a robust market base, while seniors, although initially a smaller group, are increasingly recognized due to their growing healthcare needs and awareness of treatment options. This demographic shift indicates a fundamental change in market dynamics with higher engagement for treatment solutions from diverse age groups. Growth trends indicate that as awareness and diagnosis of bunion-related issues increase among seniors, this group's proportion in the market is rapidly expanding, thereby becoming the fastest-growing segment in the Bunion Treatment Market. Additionally, factors such as rising disposable income, increased healthcare access, and targeted marketing towards seniors are driving this segment's growth. Innovative treatment solutions tailored to the senior population are emerging, indicating a response to specific healthcare needs, ultimately leading to an enhanced market reach and potential for further expansion.

Adults (Dominant) vs. Seniors (Emerging)

The adult demographic remains the dominant group in the market share, characterized by active lifestyles that often lead to foot complications such as bunions. This age group includes individuals typically between the ages of 20 and 60, who are more likely to engage in activities that may exacerbate bunion formation, thus driving demand for treatment options. On the other hand, the senior demographic is emerging as a key player in this market. With an increasing population aged 65 and older, this group is seeking effective treatments to enhance mobility and manage their foot health. The growth in this segment is largely due to heightened awareness of bunion conditions and the desire for improved quality of life, which encourages seniors to pursue therapeutic interventions.

### By Distribution Channel: Online Sales (Largest) vs. Specialty Clinics (Fastest-Growing)

The Bunion Treatment Market showcases a diverse distribution channel landscape, with online sales leading the way as the largest segment holding market share of 42%. This channel capitalizes on the growing trend of e-commerce and consumer preference for convenience. Following online sales, pharmacies and hospitals hold substantial shares, catering to patients seeking immediate access to treatments. Specialty clinics, while smaller in market share, are gaining prominence in the overall distribution strategy, reflecting a shift towards targeted care.

Pharmacies (Dominant) vs. Hospitals (Emerging)

Pharmacies represent a dominant force in the market share, distribution channels, providing easy access to over-the-counter treatments and support products. Their widespread presence enhances patient convenience and encourages ongoing engagement. In contrast, hospitals, while traditionally viewed as essential healthcare providers, are emerging as significant players in the market. They offer comprehensive treatment options, including surgical interventions and specialized consults. The evolving landscape sees hospitals adapting to include more bunion-related care, poised for growth as awareness of bunion treatments increases.

## Regional Market Share Analysis

### North America : Market Leader in Bunion Treatment

North America leads in the Bunion (Hallux Valgus) Treatment Market Size, accounting for over 44.68% of the global revenue in 2024. The region's growth is driven by increasing awareness of foot health, advancements in surgical techniques, and a rise in the aging population. Regulatory support for innovative treatment options further fuels demand, making it a key player in the global market.

- CDC data indicate that 53.2 million U.S. adults, or 21.2%, had diagnosed arthritis during 2019–2021, with 25.7 million cases among adults aged 65 and older. This substantial musculoskeletal burden reinforces demand for orthopedic assessment, mobility management, and related treatment services.

The United States stands out as the leading country, with major players like Stryker Corporation and Zimmer Biomet Holdings, Inc. dominating the landscape. The competitive environment is characterized by continuous innovation and strategic partnerships among key players. This dynamic market is expected to see further growth as healthcare providers increasingly adopt advanced treatment modalities.

- GE HealthCare supports advanced musculoskeletal imaging through MRI technologies designed for high-resolution assessment. Its MSK solutions include imaging capabilities for foot and ankle anatomy, while AIR Recon DL can provide up to 50% reduction in scan time, supporting efficient orthopedic diagnosis and treatment planning.

### Europe : Emerging Market with Growth Potential

Europe Bunion (Hallux Valgus) Treatment Market size was valued at USD 7 Million in 2024, making it the second-largest regional market with 29.79% share. Factors such as an increasing prevalence of foot disorders, heightened awareness of treatment options, and supportive healthcare policies are driving this growth. The region's regulatory frameworks are evolving to accommodate new technologies, enhancing patient access to effective treatments.

- The European Medicines Agency recommended 114 medicines for marketing authorisation in 2024, including 46 medicines containing new active substances. EMA also reported that 60% of medicines receiving positive opinions had benefited from scientific advice during development, reflecting a strong European environment for healthcare innovation and regulatory advancement.

 Leading countries like Germany and the UK are at the forefront, with key players such as B. Braun Melsungen AG and Smith & Nephew plc actively participating in the market. The competitive landscape is marked by innovation and collaboration among companies, ensuring a diverse range of treatment options for patients. As the market matures, the focus on minimally invasive procedures is expected to gain traction.

### Asia-Pacific : Rapidly Growing Bunion Treatment Sector

The Asia-Pacific region is emerging as a significant player in the bunion treatment market, with a market size of 4.5 in 2024. The growth is driven by increasing urbanization, rising disposable incomes, and a growing awareness of foot health. Additionally, supportive government initiatives aimed at improving healthcare infrastructure are expected to further boost market demand.

 Countries like Japan and Australia are leading the charge, with a competitive landscape featuring both local and international players. Companies such as Medtronic plc and Orthofix Medical Inc. are expanding their presence in the region. The focus on advanced surgical techniques and patient-centric solutions is shaping the future of bunion treatment in Asia-Pacific, making it a region to watch.

### Middle East and Africa : Emerging Market with Untapped Potential

The Middle East and Africa region is gradually developing its bunion treatment market, currently valued at 1.5 in 2024. The growth is primarily driven by increasing healthcare investments, a rising prevalence of foot-related disorders, and a growing awareness of treatment options among the population.

Regulatory bodies are beginning to implement frameworks that support the introduction of advanced medical technologies, which is expected to enhance market growth. Countries like South Africa and the UAE are leading the market, with a competitive landscape that includes both local and international players. The presence of key companies such as Hanger, Inc. and Acelity L.P. Inc. is contributing to the market's development. As healthcare access improves, the demand for effective bunion treatments is anticipated to rise significantly.

## Competitive Benchmarking

The Bunion Treatment Market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on patient-centric solutions. Key players such as Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), and B. Braun Melsungen AG (DE) are actively engaged in enhancing their product offerings and expanding their market reach. Stryker Corporation (US) has positioned itself as a leader through its commitment to technological advancements in surgical solutions, while Zimmer Biomet Holdings, Inc. (US) emphasizes a comprehensive approach to musculoskeletal health, integrating bunion treatments into a broader portfolio of orthopedic solutions.
 
B. Braun Melsungen AG (DE) focuses on developing minimally invasive techniques, which aligns with the growing demand for less invasive treatment options, thereby influencing the competitive dynamics of the market.The business tactics employed by these companies reflect a strategic emphasis on localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several players vying for market share, yet the collective influence of these key players is significant. Their ability to innovate and adapt to changing consumer preferences is likely to dictate the competitive landscape moving forward.
 
In November Stryker Corporation (US) announced the launch of a new line of advanced bunion correction devices that utilize AI-driven technology to enhance surgical precision. This strategic move not only underscores Stryker's commitment to innovation but also positions the company to capture a larger share of the market by addressing the increasing demand for technologically advanced surgical solutions. The integration of AI into surgical procedures may lead to improved patient outcomes and reduced recovery times, thereby enhancing Stryker's competitive edge.
 
In October Zimmer Biomet Holdings, Inc. (US) entered into a strategic partnership with a leading telehealth provider to offer remote consultations for bunion treatment. This collaboration is indicative of a broader trend towards digital health solutions, allowing patients to access expert advice from the comfort of their homes. By leveraging telehealth, Zimmer Biomet aims to improve patient engagement and streamline the treatment process, which could potentially lead to increased patient satisfaction and loyalty.
 
In September B. Braun Melsungen AG (DE) expanded its product line to include biodegradable implants for bunion correction, reflecting a growing trend towards sustainability in medical devices. This strategic initiative not only addresses environmental concerns but also aligns with the increasing consumer preference for eco-friendly products. By prioritizing sustainability, B. Braun may enhance its brand reputation and appeal to a more environmentally conscious consumer base.
 
As of December the competitive trends in the Bunion Treatment Market are increasingly defined by digitalization, sustainability, and the integration of advanced technologies such as AI. Strategic alliances are playing a crucial role in shaping the current landscape, enabling companies to leverage complementary strengths and enhance their market positions. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift may redefine how companies approach product development and customer engagement, ultimately leading to improved patient outcomes and satisfaction.

## Recent News & Developments

- Q3 2024: Robert Wood Johnson University Hospital (RWJUH) at New Jersey, U.S started offering the Bunionplasty 360 Bunion Repair, a minimally invasive procedure that uses small incisions and patented bone screws to realign the toe joint. In August 2024, RWJUH in New Jersey launched the Bunionplasty 360 Bunion Repair, a new minimally invasive bunion surgery technique designed to minimize scarring, reduce pain, and accelerate recovery, allowing patients to walk the same day and return to normal footwear within 6–8 weeks.

## Report Scope

| MARKET SIZE 2024 | 23.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 25.09(USD Million) |
| MARKET SIZE 2035 | 48.46(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.8% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | B. Braun Melsungen AG (DE), Stryker Corporation (US), Zimmer Biomet Holdings, Inc. (US), DePuy Synthes (US), Smith & Nephew plc (GB), Acelity L.P. Inc. (US), Medtronic plc (IE), Orthofix Medical Inc. (US), Hanger, Inc. (US) |
| Segments Covered | Treatment Type, Severity Level, Patient Demographics, Distribution Channel |
| Key Market Opportunities | Integration of advanced minimally invasive surgical techniques in the Bunion Treatment Market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation and competition in the bunion treatment market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation of the Bunion Treatment Market by 2035?**
A: The projected market valuation of the Bunion Treatment Market is expected to reach 48.46 USD Million by 2035.

**Q: What was the market valuation of the Bunion Treatment Market in 2024?**
A: The overall market valuation of the Bunion Treatment Market was 23.5 USD Million in 2024.

**Q: What is the expected CAGR for the Bunion Treatment Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Bunion Treatment Market during the forecast period 2025 - 2035 is 6.8%.

**Q: Which companies are considered key players in the Bunion Treatment Market?**
A: Key players in the Bunion Treatment Market include B. Braun Melsungen AG, Stryker Corporation, and Zimmer Biomet Holdings, Inc.

**Q: What are the main treatment types in the Bunion Treatment Market?**
A: The main treatment types in the Bunion Treatment Market include Surgical Treatment, Non-Surgical Treatment, Orthotic Devices, and Physical Therapy.

**Q: How did the valuation of Surgical Treatment compare to Non-Surgical Treatment in 2024?**
A: In 2024, the valuation of Surgical Treatment was 8.0 USD Million, while Non-Surgical Treatment was valued at 7.5 USD Million.

**Q: What is the market segmentation by severity level for bunion treatment?**
A: The market segmentation by severity level includes Mild, Moderate, and Severe, with valuations ranging from 5.0 to 20.0 USD Million.

**Q: How do patient demographics influence the Bunion Treatment Market?**
A: Patient demographics, including Age Group, Gender, and Activity Level, show valuations from 8.0 to 16.96 USD Million.

**Q: What distribution channels are utilized in the Bunion Treatment Market?**
A: Distribution channels in the Bunion Treatment Market include Online Sales, Pharmacies, Hospitals, and Specialty Clinics.

**Q: What is the projected growth trend for the Bunion Treatment Market in the coming years?**
A: The Bunion Treatment Market is likely to experience growth, with a projected valuation increase to 48.46 USD Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/bunion-treatment-market-5195*